Medical Devices Startups
6,372 companies tagged Medical Devices, with their investors and founders.
NanoString (part of Bruker Spatial Biology) develops instruments and assays for spatial biology and gene expression analysis, including single-cell and subcellular spatial transcriptomics, proteomics, and multiomics. Its systems serve researchers in oncology, biomarker discovery, neuroscience, and translational and clinical research.
2 investors
Nanovery develops DNA-based nanorobotic sensors that quantify nucleic acid sequences, such as RNA therapeutics and biomarkers, in liquid samples using a standard plate reader. The platform serves biotechnology research and therapeutic analysis workflows.
2 investors
NVA is a network of over 1,000 companion animal hospitals and 140+ specialty/emergency veterinary facilities, along with boarding, grooming, and equine care services, serving pet owners across North America. The company operates through multiple integrated business units delivering comprehensive veterinary medicine and pet care services.
2 investors
Nava develops lipid nanoparticles (LNPs) designed to deliver RNA therapeutics to specific organs and cellular targets for genetic medicine applications. The company focuses on addressing unmet medical needs across a range of RNA therapeutic treatments.
2 investors
Navitas Life Sciences is a global clinical research partner providing clinical, regulatory, safety, and data management solutions to pharmaceutical, biotech, and federal agencies for drug development and patient safety. The company combines industry expertise with proprietary technology platforms to accelerate clinical trials and regulatory processes.
2 investors
Navi develops a medical device β an ECG-based catheter tip location system for newborn and pediatric patients β to help doctors and nurses in neonatal and pediatric intensive care units deliver better vascular access care. The company works with clinicians internationally to improve pediatric patient outcomes.
2 investors
Nectero Therapeutics develops therapeutic devices for vascular medicine, working with key opinion leaders in the field. The company operates in the medical device and biotech space.
2 investors
Nectin Therapeutics develops novel monoclonal antibodies and antibody-drug-conjugates to treat difficult-to-treat cancers by targeting immune evasion mechanisms. The company is a biotech firm with a pipeline focused on oncology immunotherapy, including its lead candidate NTX1088 currently in clinical trials.
2 investors
NeoBe Therapeutics develops engineered live biotherapeutics for oncology, combining synthetic biology and immunology to create next-generation cell therapies. The company serves cancer patients through collaborations with leading academic institutions and investors.
2 investors
NeoChord develops a medical device system for beating heart mitral valve repair in patients with mitral valve regurgitation. The company's flagship product, the NeoChord Artificial Chordae Delivery System, has received CE market clearance in Europe.
2 investors
NeoDocs provides at-home health assessment tests with lab-quality accuracy and personalized health monitoring for consumers seeking preventive wellness. The company focuses on proactive health optimization rather than disease treatment.
2 investors
Neopathology develops tissue diagnostic assays and a proprietary platform called ONEPATHOLOGY that delivers rapid, accurate disease diagnosis and patient stratification for precision medicine treatments. The company combines spatial biology and deep-tissue profiling technologies to standardize tissue diagnostics.
2 investors
NervGen is a clinical-stage biotech company developing therapies for neurological conditions, with a focus on spinal cord injury and neurorepair. It maintains a drug pipeline and operates as a publicly traded company.
2 investors
NΔRx Biosciences develops small molecule inhibitors targeting DNA damage sensor proteins for cancer treatment, with initial focus on difficult-to-treat lung and ovarian cancers. The company builds on two decades of academic research from Indiana University's School of Medicine on DNA damage and repair mechanisms.
2 investors
Nesa Medtech develops GYIDE, a minimally invasive, uterus-preserving medical device that uses a guidance and planning system to deliver treatment that shrinks uterine fibroids without cutting or suturing. The company targets women's health, offering an alternative to existing surgical and non-surgical treatments for uterine fibroids.
2 investors
Neteera develops contactless sensor-based technology for continuous patient monitoring, using AI and signal processing to support clinical workflows and remote care. It sells to healthcare providers, including in the North American market.
2 investors
Neuraptive is a biotechnology company staffed by professionals with expertise in research and development, manufacturing, and commercialization in the pharmaceutical industry.
2 investors
Neuraura Biotech develops proprietary 3D micro-electrode and microsensor technology for high-fidelity neural recording and percutaneous stimulation, used to improve diagnostic and therapeutic solutions for neurological, psychiatric and sensory conditions. The company commercializes technology transferred from the University of Calgary, with a stated focus on chronic, underserved health conditions including women's health.
2 investors
Neuraworx Medical Technologies is a medical device company developing Intelligent Cerebrovascular Pacing, a bioelectronic technology intended to enhance the brain's glymphatic system function and cerebral fluid clearance. The technology targets brain health by improving removal of extracellular biomolecular debris associated with aging and disease.
2 investors
Neurelis is a neuroscience-based biopharmaceutical company that develops treatments for people living with neurological conditions such as epilepsy. It also maintains a proprietary drug delivery and stabilization technology portfolio applicable to proteins, peptides, and small and large molecules.
2 investors
NEL develops software-driven solutions for motion analysis and diagnostics to support epilepsy patients and their physicians. The company provides recording support and medical review services using automated and manual annotation of seizure events by clinical professionals.
2 investors
neurocare group operates a network of over 20 clinics across Europe, the United States, and Australia offering personalized mental health treatments such as TMS, neurofeedback, and tDCS for conditions including depression, ADHD, OCD, and sleep disorders. It also provides a Digital Therapy Platform and an online academy that trains third-party clinicians in its treatment protocols.
2 investors
Neurode develops a wearable neurostimulation headband paired with a companion app that provides personalized insights and recommendations from psychologists, neuroscientists, and engineers. The device uses clinical-grade stimulation pads and targets adults in the US managing mental health and neurological wellness.
2 investors
Neurogram develops AI-powered solutions for neurological diagnostics using brain-computer interface technology and EEG analysis. The company serves neurologists and healthcare providers seeking precision diagnostic tools grounded in neuroscience research.
2 investors